AS900672

AS900672 · Merck KGaA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AS900672, covering 2013-07-25 to 2013-07-25. Get the full timeline:

Most recent: Clinical Trial Update: AS900672-Enriched in Ovulation Induction [Phase 2]